S. Aureus Colonization in Atopic Dermatitis
Staphylococcus Aureus Colonization in Atopic Dermatitis
1 other identifier
observational
114
1 country
1
Brief Summary
The purpose of this study is to characterize the bacterial strains that colonize children with atopic dermatitis. The investigators hypothesize that rectal cultures will be more sensitive than anterior nares cultures for detecting S. aureus colonization, and that strains of S. aureus colonizing patients with atopic dermatitis will be resistant to commonly used topical antibiotic ointments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 17, 2014
CompletedFirst Posted
Study publicly available on registry
March 19, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 11, 2017
CompletedJanuary 10, 2022
January 1, 2022
5 years
March 17, 2014
January 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in rectal and nasal S. aureus colonization rates in a population of children with atopic dermatitis
Up to 3 years
Secondary Outcomes (1)
Rates of resistance to commonly used topical antibiotic ointments in strains of S. aureus that colonize a population of children with atopic dermatitis
Up to 20 years
Eligibility Criteria
Subjects will be recruited from the pediatric dermatology faculty practices and resident clinics at CUMC as well as from the units of the Morgan Stanley Children's Hospital of New York. As per CUMC policy, the investigators will not directly approach potential subjects until the subject's physician has ascertained and documented that their patient is willing to discuss the research with the investigators.
You may qualify if:
- subjects with a diagnosis of atopic dermatitis seen by the Columbia University Medical Center department of dermatology
- subjects ages 0 to 18 years
You may not qualify if:
- those patients in which a definitive diagnosis of AD cannot be made
- subjects over the age of 18 years old
- subjects with evidence of acute systemic illness
- subjects currently taking systemic antibiotics
- subjects with viral or fungal skin infection
- any individual who declines participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- Society for Pediatric Dermatologycollaborator
Study Sites (1)
Columbia University Medical Center / Department of Dermatology
New York, New York, 10032, United States
Biospecimen
Skin culture specimens are retained
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christine T Lauren, MD
Columbia University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2014
First Posted
March 19, 2014
Study Start
December 1, 2011
Primary Completion
December 1, 2016
Study Completion
January 11, 2017
Last Updated
January 10, 2022
Record last verified: 2022-01